Key Insights

Highlights

Treatment Research

3 treatments under study, led by Homologous Recombination Deficiency Hrd

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Homologous Recombination Deficiency Hrd1
  • Alkros1met1
  • Standard Care Treatment1

Active Sponsors

  • National Cancer Center Korea1

Related Conditions

  • Advanced Solid Tumors1
  • Metastatic Solid Tumors1
  • Proteogenomic Screening And Molecular Signaling1
  • Locally Advanced Solid Tumors1
  • Recurrent Solid Tumors1

Activity Timeline